Correlation Between Dominari Holdings and Arrowhead Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Dominari Holdings and Arrowhead Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dominari Holdings and Arrowhead Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Dominari Holdings and Arrowhead Pharmaceuticals, you can compare the effects of market volatilities on Dominari Holdings and Arrowhead Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dominari Holdings with a short position of Arrowhead Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dominari Holdings and Arrowhead Pharmaceuticals.

Diversification Opportunities for Dominari Holdings and Arrowhead Pharmaceuticals

-0.28

Correlation Coefficient

Dominari Holdings  Arrowhead Pharmaceuticals

Very good diversification

The 3 months correlation between Dominari and Arrowhead is -0.28. Overlapping area represents the amount of risk that can be diversified away by holding Dominari Holdings and Arrowhead Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Arrowhead Pharmaceuticals and Dominari Holdings is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dominari Holdings are associated (or correlated) with Arrowhead Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Arrowhead Pharmaceuticals has no effect on the direction of Dominari Holdings i.e., Dominari Holdings and Arrowhead Pharmaceuticals go up and down completely randomly.

Pair Corralation between Dominari Holdings and Arrowhead Pharmaceuticals

Given the investment horizon of 90 days Dominari Holdings is expected to under-perform the Arrowhead Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Dominari Holdings is 1.28 times less risky than Arrowhead Pharmaceuticals. The stock trades about -0.04 of its potential returns per unit of risk. The Arrowhead Pharmaceuticals is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest  2,149  in Arrowhead Pharmaceuticals on September 13, 2024 and sell it today you would earn a total of  124.00  from holding Arrowhead Pharmaceuticals or generate 5.77% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Dominari Holdings  vs.  Arrowhead Pharmaceuticals

Dominari Holdings

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Dominari Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's primary indicators remain strong and the recent confusion on Wall Street may also be a sign of long-lasting gains for the firm traders.

Arrowhead Pharmaceuticals

Risk-Adjusted Performance

3 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Arrowhead Pharmaceuticals are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Even with relatively unsteady basic indicators, Arrowhead Pharmaceuticals may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Pair Trading with Dominari Holdings and Arrowhead Pharmaceuticals

The main advantage of trading using opposite Dominari Holdings and Arrowhead Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dominari Holdings position performs unexpectedly, Arrowhead Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Arrowhead Pharmaceuticals will offset losses from the drop in Arrowhead Pharmaceuticals' long position.

The idea behind Dominari Holdings and Arrowhead Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.